The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Abstract
Background —Vascular endothelial growth factor (VEGF) is being investigated for therapeutic angiogenesis in ischemic myocardium. Primarily, transient delivery systems have been tested. The goal of this study was to investigate the effects of continuous expression of VEGF in myocardium by use of myoblast-mediated delivery. Methods and Results —Primary murine myoblasts (5×10 5 cells in 10 μL of PBS with 0.5% BSA) expressing both the murine VEGF gene and the β-galactosidase (β-gal) gene from a retroviral promoter were implanted in the ventricular wall of immunodeficient mice (n=11) via a subdiaphragmatic approach. Control immunodeficient mice (n=12) were injected with the same number of myoblasts expressing only the β-gal gene. Between days 14 and 16, surviving mice were euthanized and the hearts processed for histology. In the experimental group, 11 of 11 mice demonstrated failure to thrive by day 13; 5 deaths occurred between days 8 and 15. There were no complications in the control mice. Histochemistry documented successful implantation of myoblasts (positive β-gal reaction product) in 6 of 6 surviving experimental mice and 12 of 12 controls. Histology disclosed intramural vascular tumors resembling hemangiomas in the VEGF-myoblast–injected myocardium in 6 of 6 surviving mice. β-Gal–expressing cells were present at the site of the vascular tumors. Immunohistochemistry localized abundant endothelial nitric oxide synthase and CD31 (platelet and endothelial cell adhesion molecule) within the lesion, consistent with the presence of endothelial cells. Conclusions —In this model, unregulated continuous expression of VEGF is associated with (1) a high rate of failure to thrive/death and (2) formation of endothelial cell–derived intramural vascular tumors in the implantation site. These results underscore the importance of regulating VEGF expression for therapeutic angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Self-citationRosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Skeletal myoblast transplantation for repair of myocardial necrosis.
Murry, C. E., Wiseman, R. W., Schwartz, S. M., & Hauschka, S. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119070 · Cited by 615
Banai, S., Jaklitsch, M. T., Shou, M., Lazarous, D. F., Scheinowitz, M., Biro, S., Epstein, S. E., & Unger, E. F. (1994) · Circulation · doi:10.1161/01.cir.89.5.2183 · Cited by 596
Reinecke, H., Zhang, M., Bartosek, T., & Murry, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.2.193 · Cited by 515
Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Self-citationTremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., & Richards, C. L. (1993) · Cell Transplantation · doi:10.1177/096368979300200203 · Cited by 345
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
Vascularization in tissue engineering
Rouwkema, J., Rivron, N. C., & van Blitterswijk, C. A. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.009 · Cited by 1,211
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Ouriel, K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06351-6 · Cited by 865
Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G., & Gurtner, G. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63754-6 · Cited by 798
Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.-C., Cummins, J., & Huard, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15153 · Cited by 733
Cao, R., Bråkenhielm, E., Pawliuk, R., Wariaro, D., Post, M. J., Wahlberg, E., Leboulch, P., & Cao, Y. (2003) · Nature Medicine · doi:10.1038/nm848 · Cited by 721
Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646
Iwaguro, H., Yamaguchi, J.-I., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S.-I., Silver, M., Li, T., Isner, J. M., & Asahara, T. (2002) · Circulation · doi:10.1161/hc0602.103673 · Cited by 588
Zisch, A. H., Lutolf, M. P., Ehrbar, M., Raeber, G. P., Rizzi, S. C., Davies, N., Schmökel, H., Bezuidenhout, D., Djonov, V., Zilla, P., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1041fje · Cited by 534
Ozawa, C. R., Banfi, A., Glazer, N. L., Thurston, G., Springer, M. L., Kraft, P. E., McDonald, D. M., & Blau, H. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18420 · Cited by 520
Self-citationVascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Zhang, M., Mal, N., Kiedrowski, M., Chacko, M., Askari, A. T., Popovic, Z. B., Koc, O. N., & Penn, M. S. (2007) · The FASEB Journal · doi:10.1096/fj.06-6558com · Cited by 457
Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function
Li, W., Ma, N., Ong, L.-L., Nesselmann, C., Klopsch, C., Ladilov, Y., Furlani, D., Piechaczek, C., Moebius, J. M., Lützow, K., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0771 · Cited by 440
Hsiao, S. T.-F., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0674 · Cited by 410
Zhang, Z. G., Zhang, L., Tsang, W., Soltanian-Zadeh, H., Morris, D., Zhang, R., Goussev, A., Powers, C., Yeich, T., & Chopp, M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00002 · Cited by 402
Dor, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1939 · Cited by 390
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/80430 · Cited by 370
Biopolymeric delivery matrices for angiogenic growth factors
Zisch, A. H., Lutolf, M. P., & Hubbell, J. A. (2003) · Cardiovascular Pathology · doi:10.1016/s1054-8807(03)00089-9 · Cited by 357
Ehrbar, M., Djonov, V. G., Schnell, C., Tschanz, S. A., Martiny-Baron, G., Schenk, U., Wood, J., Burri, P. H., Hubbell, J. A., & Zisch, A. H. (2004) · Circulation Research · doi:10.1161/01.res.0000126411.29641.08 · Cited by 357
Ouchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y., & Walsh, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803440200 · Cited by 338
Fibroblast growth factor regulation of neovascularization
Murakami, M., & Simons, M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f97d98 · Cited by 321
Melo, L. G., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A. A., Ehsan, A., Griese, D. P., Dell’Acqua, G., Mann, M. J., Oyama, J., et al. (2002) · Circulation · doi:10.1161/hc0502.103363 · Cited by 303
Chiu, L. L. Y., & Radisic, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.039 · Cited by 302
Elson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 299
Microscale tissue engineering using gravity-enforced cell assembly
Kelm, J. M., & Fussenegger, M. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.02.002 · Cited by 297
Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach
Tam, R. Y., Fuehrmann, T., Mitrousis, N., & Shoichet, M. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.237 · Cited by 293
Gordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A. (2004) · Blood · doi:10.1182/blood-2003-07-2535 · Cited by 273
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Kinnaird, T., Stabile, E., Burnett, M. S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000137878.26174.66 · Cited by 265
Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration
Cattelan, G., Guerrero Gerbolés, A., Foresti, R., Pramstaller, P. P., Rossini, A., Miragoli, M., & Caffarra Malvezzi, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00414 · Cited by 152
Awada, H. K., Johnson, N. R., & Wang, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.034 · Cited by 138
Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., & Giacca, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00034-0 · Cited by 108
Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction
Xu, Q., Xiao, Z., Yang, Q., Yu, T., Deng, X., Chen, N., Huang, Y., Wang, L., Guo, J., & Wang, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100978 · Cited by 77
“Additionally, it has been observed that systemic VEGF injection may result in off-target angiogenesis at off-target areas, causing major adverse responses, making a person more susceptible to vascular leakage, hypotension, and tumor development [147].”
BackgroundTakayama, K., Kawakami, Y., Mifune, Y., Matsumoto, T., Tang, Y., Cummins, J. H., Greco, N., Kuroda, R., Kurosaka, M., Wang, B., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.036 · Cited by 71
Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules
Hsu, C.-W., Poché, R. A., Saik, J. E., Ali, S., Wang, S., Yosef, N., Calderon, G. A., Scott, L., Vadakkan, T. J., Larina, I. V., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131643 · Cited by 56
“For instance, data from some therapeutic trials show tremendous promise using VEGF [14,15], but others indicate that delivery of VEGF via diffusion may not be the most effective way to induce stable vessels either to repair damaged tissues or to promote host perfusion of tissue constructs [16–18], and animal studies s…”
Background
Metadata
- Authors
- Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M.
- Venue
- Circulation
- Published
- 2000-08-22
- Volume
- 102
- Issue
- 8
- Pages
- 898-901
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2119841264
- Cited by
- 697
- References
- 27
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.